Xylazine

DB11477InvestigationalVet approvedSmall molecule

Xylazine is a non-opioid and clonidine analog with analgesic and muscle relaxant properties used as a tranquilizer used in veterinary medicine. It acts as an agonist at α2 adrenoceptors; however, its affinity is lower than the one reported for other α2 adrenergic receptor agonists such as detomidine and medetomidine.

Chemical structure of Xylazine
Mechanism
Curator reviewed
Formula / weight
C12H16N2S · 220.33 g/mol (avg)
Code names
BAY 1470 · WH 7286

Resolves to

Compound
UNII2KFG9TP5V8CAS7361-61-7ChEMBLCHEMBL297362ChEBI92386KEGGD08683
Clinical / RWD
RxNorm1099660
Structure
InChIKeyBPICBUSOMSTKRF-UHFFFAOYSA-NSMILESCC1=CC=CC(C)=C1NC1=NCCCS1
Targets
P18825ADRA2CP18089ADRA2B

What you can answer from here — as of September 11, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,157Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Xylazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In